Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ·Healthcare·Biotechnology
$1.59
+0.63%
Mkt Cap $93.28M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 27, 2026 | $4.77M | — | — | -$0.14 | -$0.11 | +21.43% | — | — |
| Q4 2025 Nov 5, 2025 | $24.25M | — | — | -$0.17 | -$0.13 | +23.53% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.21 | -$0.16 | +23.81% | — | — |
| Q2 2025 May 14, 2025 | -$666.67K | — | — | -$0.25 | -$0.17 | +32.00% | — | — |
| Q1 2025 Feb 28, 2025 | — | $244.53K | — | -$0.25 | -$0.27 | -8.00% | — | — |
| Q4 2024 Nov 7, 2024 | $28.43M | — | — | -$0.25 | -$0.25 | +0.00% | — | — |
| Q3 2024 Aug 1, 2024 | — | — | — | -$0.14 | -$0.28 | -100.00% | — | — |
| Q2 2024 May 2, 2024 | $2.00M | — | — | -$0.08 | -$0.14 | -75.00% | — | — |
| Q1 2024 Mar 7, 2024 | $3.00M | $392.62K | -86.91% | -$0.21 | -$0.08 | +61.90% | — | — |
| Q4 2023 Nov 3, 2023 | $290.00K | — | — | -$0.24 | -$0.14 | +41.67% | — | — |
| Q3 2023 Aug 3, 2023 | — | — | — | -$0.31 | -$0.15 | +51.61% | — | — |
| Q2 2023 May 4, 2023 | — | — | — | -$0.30 | -$0.27 | +10.00% | — | — |
| Q1 2023 Mar 9, 2023 | — | — | — | -$0.34 | -$0.22 | +35.29% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$0.34 | -$0.25 | +26.47% | — | — |
| Q3 2022 Aug 5, 2022 | — | — | — | -$0.32 | -$0.30 | +6.25% | — | — |
| Q2 2022 May 5, 2022 | — | — | — | -$0.31 | -$0.29 | +6.45% | — | — |
| Q1 2022 Mar 17, 2022 | — | — | — | -$0.31 | -$0.27 | +12.90% | — | — |
| Q4 2021 Oct 28, 2021 | — | — | — | -$0.29 | -$0.27 | +6.90% | — | — |
| Q3 2021 Aug 5, 2021 | — | — | — | -$0.27 | -$0.28 | -3.70% | — | — |
| Q2 2021 May 6, 2021 | — | — | — | -$0.29 | -$0.25 | +13.79% | — | — |